NanoViricides Stock Price - NNVC

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
NanoViricides Inc NNVC AMEX Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.06 1.82% 3.36 3.5261 3.3104 3.41 3.30 20:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
212 34,473 $ 3.39 $ 116,993 59,099 0.16045 - 4.28
Last Trade Time Type Quantity Stock Price Currency
20:00:00 3,050 $ 3.36 USD

NanoViricides Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 12.95M 3.85M $ -8.56M -2.33 - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
192.31k $ - 0.00% - -

more financials information »

NanoViricides News

Loading Messages....

Latest NNVC Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NNVC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.094.242.703.20112,2540.278.74%
1 Month2.904.282.253.1681,9050.4615.86%
3 Months2.264.281.852.8840,5041.1048.67%
6 Months0.24284.280.160451.1881,7203.121,283.86%
1 Year0.26014.280.160450.5459559170,2133.101,191.81%
3 Years1.324.280.160450.6917755132,5652.04154.55%
5 Years2.794.280.160451.20144,0910.5720.43%

NanoViricides Description

Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.